BioCentury
ARTICLE | Clinical News

NMP22 BladderChek regulatory update

September 27, 2004 7:00 AM UTC

Matritech Inc. (MZT), Newton, Mass. Product: NMP22 BladderChek Business: Diagnostic Health Canada approved NMP22 BladderChek, an assay to detect nuclear matrix protein NMP22 in urine, to diagnose an...